ArticleArchives of women's mental health2025
Sex comparisons on the beneficial effects of an early intervention program in a patients' cohort with first episode psychosis: what effectiveness in women?
Article in Archives of women's mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMales and females with First Episode Psychosis (FEP) usually tend to differ in psychopathology, clinical presentation and their longitudinal trajectory. This study aimed to examine the difference of effectiveness of specialized psychosocial and pharmacological treatments for FEP, focusing on various clinical and functioning outcomes across a 2-years follow-up period.
methodsThe assessment included the CAARMS, the HoNOS, the PANSS and the GAF scale and was conducted at baseline and every 12 months.
results490 FEP patients (age: 12-35 years) were recruited. Of them, 363 completed the follow-up (132 females and 231 males). At baseline, males showed a higher prevalence rate of schizophrenia diagnosis (56.1% VS 43.8%; p = .008), whereas females a higher prevalence rate of affective psychosis (36.2% VS 23.3%; p = .005). Male participants also showed a more consistent substance abuse (46.9% VS 24.3%; p = .0001), lower years of education (11.26 ± 2.94 VS 11.88 ± 2.68; p = .013), and more striking behavioral manifestations (4.06 ± 2.36 VS 3.39 ± 2.58; p = .003) compared to women. Our 2-year outcome parameter results showed a higher incidence of functional remission over time in females compared to males (49.2% VS 39.0%; p = .028), together with a decreasing trend in new hospitalization rates (17.8% VS 26.9%; p = .089). Independently from sex, our results also showed a statistically significant reduction in the prescription of psychotropic medications and through the increase of all psychosocial interventions, although more evident in males.
conclusionThese results suggested that specialized interventions for FEP are overall effective in both treated subgroups. Additionally, FEP women specifically showed higher rates of improvement in functional outcome variables over time when compared to males.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.